{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:57:27Z","timestamp":1789156647035,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["13GW0313A, 13GW0313B, 13GW0449A and 13GW0449B"],"award-info":[{"award-number":["13GW0313A, 13GW0313B, 13GW0449A and 13GW0449B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antimicrobial coatings of implants are of interest to reduce infection rate in orthopedic surgery. Demonstration of clinical effectiveness of such coated implants to obtain market approval is challenging. The objective of this article is to define a design for a randomized controlled trial to evaluate the clinical performance of a silver-coating for locking plates for fracture treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study design has to respect different criteria, such as feasibility, focus on overall complications, such as functional impairment, fracture healing, and particularly on infection rates. Distal tibia fractures were chosen due to the high prevalence of infections in this type of injuries, which warrants a particular benefit of antimicrobial prophylaxis and thus might allow to see a statistical trend in favor of the coated product. The study design was defined as a randomized, controlled, subject and observer-blinded, multi-center study in subjects with fractures of the distal tibia with a total of 226 patients. A number of 113 patients are planned for each of the two treatment arms with treatment of the fracture with a silver-coated device (first arm) or with an uncoated device (second arm). Inclusion criteria are closed fractures of the distal tibia according to the Tscherne-Oestern classification or open fractures of the distal tibia according to the Gustilo-Anderson classification in subjects older than 18 years. Primary outcome parameter is the Anticipated Adverse Device Effects (AADE) including all typical complications of this type of injury, such as functional impairment of the affected limb, non-union, and infections based on a non-inferiority study design. Also, silver-typical complications, such as argyria, are included. Secondary parameters are infection rates and fracture healing. Follow-up of patients includes five visits with clinical and X-ray evaluations with a follow-up time of 12 months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Demonstration of clinical effectiveness of antimicrobial coatings of fracture fixation devices remains a challenge. Definition of a prospective randomized pre-market trial design and recruitment of clinical sites for such a study is possible. A confirmative proof of the expected clinical benefit in terms of reduction of device-related infections will be addressed with a prospective post-market clinical follow-up study in a second step due to the large sample size required.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT05260463. Registered on 02 March 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06919-0","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:19:54Z","timestamp":1669918794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Silver-coated versus uncoated locking plates in subjects with fractures of the distal tibia: a randomized, subject and observer-blinded, multi-center non-inferiority study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-0507","authenticated-orcid":false,"given":"S.","family":"Schoder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Alt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"issue":"5","key":"6919_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1302\/2046-3758.105.BJR-2020-0532","volume":"10","author":"N Walter","year":"2021","unstructured":"Walter N, et al. Long-term patient-related quality of life after fracture-related infections of the long bones. Bone Joint Res. 2021;10(5):321\u20137.","journal-title":"Bone Joint Res"},{"issue":"11","key":"6919_CR2","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.I.01131","volume":"92","author":"LA Poultsides","year":"2010","unstructured":"Poultsides LA, Liaropoulos LL, Malizos KN. The socioeconomic impact of musculoskeletal infections. J Bone Joint Surg Am. 2010;92(11):e13.","journal-title":"J Bone Joint Surg Am"},{"key":"6919_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.injury.2016.12.011","volume":"48","author":"V Alt","year":"2017","unstructured":"Alt V. Antimicrobial coated implants in trauma and orthopaedics-A clinical review and risk-benefit analysis. Injury. 2017;48:599\u2013607.","journal-title":"Injury."},{"key":"6919_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0966-842X(97)01033-0","volume":"5","author":"J Davies","year":"1997","unstructured":"Davies J, Wright GD. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 1997;5:234\u201340.","journal-title":"Trends Microbiol"},{"key":"6919_CR5","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1016\/j.biomaterials.2007.02.033","volume":"28","author":"J Hardes","year":"2007","unstructured":"Hardes J, et al. Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials. 2007;28:2869\u201375.","journal-title":"Biomaterials."},{"key":"6919_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jso.21498","volume":"101","author":"J Hardes","year":"2010","unstructured":"Hardes J, et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol. 2010;101:389\u201395.","journal-title":"J Surg Oncol"},{"key":"6919_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1302\/0301-620X.97B2.34554","volume":"97-B","author":"H Wafa","year":"2015","unstructured":"Wafa H, et al. Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. Bone Joint J. 2015;97-B:252\u20137.","journal-title":"Bone Joint J."},{"key":"6919_CR8","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.arth.2016.04.009","volume":"31","author":"CP Wilding","year":"2016","unstructured":"Wilding CP, et al. Can a Silver-Coated Arthrodesis Implant Provide a Viable Alternative to Above Knee Amputation in the Unsalvageable, Infected Total Knee Arthroplasty? J Arthroplasty. 2016;31:2542\u20137.","journal-title":"J Arthroplasty"},{"key":"6919_CR9","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1302\/0301-620X.98B8.36400","volume":"98-B","author":"AD Duckworth","year":"2016","unstructured":"Duckworth AD, et al. Type C tibial pilon fractures: short- and long-term outcome following operative intervention. Bone Joint J. 2016;98-B:1106\u2013011.","journal-title":"Bone Joint J."},{"key":"6919_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.injury.2020.02.115","volume":"51","author":"D Arens","year":"2020","unstructured":"Arens D, et al. Antimicrobial silver-coating for locking plates shows uneventful osteotomy healing and good biocompatibility results of an experimental study in rabbits. Injury. 2020;51:830\u20139.","journal-title":"Injury."},{"key":"6919_CR11","first-page":"111","volume":"85","author":"H Tscherne","year":"1982","unstructured":"Tscherne H, Oestern HJ. A new classification of soft-tissue damage in open and closed fractures. Unfallheilkunde. 1982;85:111\u20135.","journal-title":"Unfallheilkunde."},{"key":"6919_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s11999-016-4980-3","volume":"475","author":"DA Ibrahim","year":"2017","unstructured":"Ibrahim DA, et al. Classifications In Brief: The Tscherne Classification of Soft Tissue Injury. Clin Orthop Relat Res. 2017;475:560\u20134.","journal-title":"Clin Orthop Relat Res"},{"key":"6919_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2106\/00004623-197658040-00004","volume":"58","author":"RB Gustilo","year":"1976","unstructured":"Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58:453\u20138.","journal-title":"J Bone Joint Surg Am"},{"key":"6919_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/00005373-198408000-00009","volume":"24","author":"RB Gustilo","year":"1984","unstructured":"Gustilo RB, Mendoza RM, Williams DN. Problems in management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. 1984;24:742\u20136.","journal-title":"J Trauma"},{"key":"6919_CR15","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.injury.2016.04.025","volume":"47","author":"B Viberg","year":"2016","unstructured":"Viberg B, et al. Complications and functional outcome after fixation of distal tibia fractures with locking plate \u2013 A multicentre study. Injury. 2016;47:1514\u20138.","journal-title":"Injury."},{"key":"6919_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.injury.2006.06.002","volume":"37","author":"S Hazarika","year":"2006","unstructured":"Hazarika S, Chakravarthy J, Cooper J. Minimally invasive locking plate osteosynthesis for fractures of the distal tibia\u2014Results in 20 patients. Injury. 2006;37:877\u201387.","journal-title":"Injury."},{"key":"6919_CR17","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1302\/0301-620X.95B7.31124","volume":"95-B","author":"M Glehr","year":"2013","unstructured":"Glehr M, et al. Argyria following the use of silver-coated megaprostheses: No association between the development of local argyria and elevated silver levels. Bone Joint J. 2013;95-B:988\u201392.","journal-title":"Bone Joint J"},{"key":"6919_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.fas.2013.12.004","volume":"20","author":"C Bastias","year":"2014","unstructured":"Bastias C, et al. Are locking plates better than non-locking plates for treating distal tibial fractures? Foot Ankle Surg. 2014;20:115\u20139.","journal-title":"Foot Ankle Surg"},{"key":"6919_CR19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00264-009-0880-4","volume":"34","author":"RK Gupta","year":"2010","unstructured":"Gupta RK, et al. Locking plate fixation in distal metaphyseal tibial fractures: series of 79 patients. Int Orthop. 2010;34:1285\u201390.","journal-title":"Int Orthop"},{"key":"6919_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/BOT.0b013e3181d04bc0","volume":"24","author":"TO White","year":"2010","unstructured":"White TO, et al. The results of early primary open reduction and internal fixation for treatment of OTA 43.C-type tibial pilon fractures: a cohort study. J Orthop Trauma. 2010;24:757\u201363.","journal-title":"J Orthop Trauma"},{"key":"6919_CR21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.injury.2003.08.015","volume":"35","author":"T Borg","year":"2004","unstructured":"Borg T, Larsson S, Lindsj\u00f6 U. Percutaneous plating of distal tibial fractures. Injury. 2004;35:608\u201314.","journal-title":"Injury."},{"key":"6919_CR22","volume-title":"2021-6. Regulation (EU) 2017\/745 \u2013 Questions & Answers regarding clinical investigation","author":"MDCG","year":"2021","unstructured":"MDCG. 2021-6. Regulation (EU) 2017\/745 \u2013 Questions & Answers regarding clinical investigation. 2021."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06919-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06919-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06919-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:22:01Z","timestamp":1669918921000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06919-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6919"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06919-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"2 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was obtained by the Ethics Committee of the Justus Liebig University Giessen Medical Faculty prior to study start (Ethik-Kommission des Fachbereichs Medizin der Justus-Liebig Universit\u00e4t Giessen, AZ 32\/19). The trial was registered at ClinicalTrials.gov (NCT05260463) on 02.MAR.2022. Written informed consent will be obtained from each patient after an oral and written information. Participating subjects can withdraw their consent at any time without giving a reason. An insurance covers the subjects with respect to the risks involved in this study according to the clinical investigation plan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"This manuscript does not contain individual personal data from patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"968"}}